NCT06082817: An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD
- State
- Not started
- Phase
- Phase 2
- People
- 30 planned
- Started
- 1 Jan 2025
- Primary completion
- 31 Dec 2025
- Arms
- Active
- Results
- None posted
- 13 Oct 2023: Trial registered